Central Drugs Standard Control Organization

Directorate General of Health Services
Ministry of Health & Family Welfare
Government of India

Downloads/Documents & Publications

S.No.
Title Downlaod (pdf) File Size
1 Guidance document for Veterinary Biologicals 2478 KB
2 Annual performance Appraisal Reports (ACR group C)(Related to Employees) 3,030kb
3 Travelling allowance bill for tour(Related to Employees) 334kb
4 Application for leave or for extension of leave(Related to Employees) 979kb
5 Leave Travel Concession Bill(Related to Employees) 1,631kb
6 TRAVELLING ALLOWANCE BILL FOR TRANSFER 622kb
7 Organ(s) and tissue(s) Donor Form 254kb
8 Advance LTC Form(Related to Employees) 334kb
9 Joining Report after EL 121kb
10 Assessment report Form 1,396kb
11 Nomination Form 2,723kb
12 Annual performance Appraisal Reports (ACR group A-B)(Related to Employees) 2,540kb
13 Medical reimbursement claim Form(Related to Employees) 484kb
14 Application for withdrawal from G.P.F Form(Related to Employees) 243kb
15 Adverse Drugs Reaction Reporting Form 712kb
16 Annexure Sheet for submit the Application Form(For Stakeholders) 64kb
17 Guidelines under new penal Provision 199kb
18 Challan (TR-6) for depositing fee(For Stakeholders) 10kb
19 Good Manufacturing Practices 282kb
20 Proforma for Drugs Controller Reporting activities 13kb
21 Right to Information Act, 2005 (RTI) - Application Form 56kb
22 Application for advance G.P.F Form(Related to Employees) 957kb
23 The Drugs & Cosmetics (Amendment) Act, 2008 and Guidelines 5,058kb
Date
Documents Pdf
1 Pantoprazole Sodium IP Aspirin IP Capsules 664 KB
2 Fingolimod capsule 2608 KB
3 Ivabradin Tablet 2543 KB
4 Evenamide(NW-3509/008/II/2019) 375 KB
5 PF-06741086 493 KB
6 Capmatinib 249 KB
7 Remogliflozin Etabonate Vildagliptin film coated tablet 1222 KB
8 Hydrocortisone Acetate 358 KB
9 Ripasudil HCl Hydrate eq. To Ripasudil Timolol Maleate IP Eq. To to Timolol eye drops 1008 KB
10 Cephalexin extended release Clavulanate Potassium tablet 1016 KB
11 Ceftazidime 321 KB
12 Goserelin 3.6 mg Injection 495 KB
13 Triamcinolone acetonide IP Lignocaine HCl IP Gel 712 KB
14 GSK2831781 502 KB
15 Ceftazidime-Avibactam 489 KB
16 Gepotidacin 256 KB
17 Lipidol 3028 KB
18 Evenamide(nw-3509) 509 KB
19 Evenamide(NW-3509/006/III/2019) 509 KB
20 Prohance® (Gadoteridol 279.3 mg/mllnjection 2667 KB
21 Dalbavancin 2754 KB
22 Azelnidipine Olmesartan Medoxomil IP tablets 1260 KB
23 opivacaine Hydrochloride USP eq. to anhydrous Ropivacaine hydrochloride Dextrose IP per ml injection 959 KB
24 Benidipine HCl Chlorthalidone IPTelmisartan IP Film coated bilayered tablets 876 KB
25 Rosuvastatin IP Teneligliptin Film coated tablet 1099 KB
26 SB3 249 KB
27 Baricitinib eli lily 509 KB
28 TRUNCATE – TB (tuberculosis) 3884 KB
29 Lenvatinib Capsules 4 mg and 10 mg 330 KB
30 Azilsartan KamedoxomilChlorthalidone IP tablet 654 KB
31 Ticagrelor 120/180 mg SR Tablet 2652 KB
32 Desidustat Tablet versus Epoetin alfa Injection 2558 KB
33 AUR101 3310 KB
34 AUR101 3310 KB
35 PNB-001 267 KB
36 Zileuton Ointment 1.25% and 5.0% 702 KB
37 Avanafil tablets 100 mg & 200 mg 1223 KB
38 Brazikumab 491 KB
39 Etrasimod( IQVIA RDS) 513 KB
40 Etrasimod( IQVIA) 502 KB
41 Etrasimod 485 KB
42 FEIBA 403 KB
43 CT-P13 471 KB
44 Inotuzumab 370 KB
45 Iodixanol 2023 KB
46 LNP023 366 KB
47 Concizumab Prophylaxis 508 KB
48 Concizumab 327 KB
49 LNP023(Rituximab) 260 KB
50 Oral Baricitinib 503 KB
51 Ruxolitinib 310 KB
52 Ruxolitinib 310 KB
53 GSK3196165 284 KB
54 Apremilast Film Coated 10/10/30mg Tablets 2755 KB
55 Spironolactone Topical Cream 5% 1495 KB
56 Tenofovir Alafenamide, Emtricitabine and Bictegravir 2682 KB
57 Sofosbuvir 400 mg Tablet 2627 KB
58 Cilnidipine IP Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil tablets 609 KB
59 Benidipine HCl IPTelmisartan IP Film coated tablets 641 KB
60 Azelnidipine Telmisartan tablets 624 KB
61 Methylcobalamin Nasal spray 500 mcg 284 KB
62 Certican / Zortress(everolimus EVR) 312 KB
63 Tirzepatide 313 KB
64 Tirzepatide1 313 KB
65 QL1205 Versus Lucentis 304 KB
66 Bupivacaine Hydrochloride IP eq. to anhydrous Bupivacaine Hydrochloride Fentanyl Citrate IP Eq. to Fentanyl injection 672 KB
67 AT-10 (2-oxoclopidogrel bisulfate 2845 KB
68 HP-hMG and Menopur® 2143 KB
69 Brazikumab 393 KB
70 Meningococcal Conjugate Vaccine 510 KB
71 semaglutide versus placebo 477 KB
72 Ribociclib plus goserelin acetate 434 KB
73 evenamide or placebo 273 KB
74 Leuprolide acetate 2291 KB
75 MYL-1701P and Eylea 299 KB
76 Netarsudil Ophthalmic solution 0.02% 3055 KB
77 ligelizumab (QGE031) 328 KB
78 Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial) 710 KB
79 Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial) 710 KB
80 Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial) 710 KB
81 Efonidipine Hydrochloride Ethanolate + Telmisartan IP + Chlorthalidone IP Tablets (Phase III Clinical Trial 705 KB
82 Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium + Cilnidipine IP film coated tablet (Phase III Clinical Trial) 697 KB
83 Mirikizumab 625 KB
84 Tranexamic acid 1667 KB
85 Menopausal Gonadotropin 2618 KB
86 Azelnidipine IP + Chlorthalidone IP Uncoated Tablet (Phase III Clinical Trial) 617 KB
87 k0706 592 KB
88 baloxavir marboxil 492 KB
89 Semaglutide 2366 KB
90 traconazole 1373 KB
91 Semaglutide (SOUL) 2366 KB
92 Mirikizumab (UC) 625 KB
93 Filgotinib (rheumatoid Arthritis) 519 KB
94 Filgotinib 591 KB
95 Fluticasone Propionate + Salmeterol inhalation Powder (Phase III Clinical Trial) 531 KB
96 Fluticasone Propionate + Salmeterol inhalation Powder (Phase III Clinical Trial) 531 KB
97 Capivasertib + Paclitaxel versus placebo 228 KB
98 Tigilanol Tiglate 368 KB
99 HD204 to Avastin® 513 KB
100 Baricitinib 500 KB
101 Evenamide 608 KB
102 Baricitinib 500 KB
103 Oral Baricitinib 316 KB
104 Aceclofenac Topical ointment 1.5% w/wIII 2285 KB
105 Beclomethasone 1765 KB
106 Evenamide 608 KB
107 IVIEW-1201 264 KB
108 Ulipristal acetate tablet 30mgIII 2555 KB
109 Sertaconazole Nitrate + Terbinafine HCl cream (Phase III Clinical Trial) 643 KB
110 INTP24 against Avastin® in 468 KB
111 Ribiciclib 289 KB
112 PMZ-1620 320 KB
113 PMZ-1620 320 KB
114 Benidipine Hydrochloride + Metoprolol Succinate eq. to Metoprolol tartrate IP Film coated tablet (Phase III Clinical Trial) 357 KB
115 Adenosine IP + Minoxidil IP Topical solution (Phase II Clinical Trial) 626 KB
116 Benidipine Hydrochloride JP + Chlorthalidone IP Film coated tablets (Phase III Clinical Trial 580 KB
117 Lenalidomide 267 KB
118 AS012 230 KB
119 Osimertinib in Combination with Savolitinib 492 KB
120 Crizanlizumab 303 KB
121 Saroglitazar tablet 4mg II 2058 KB
122 Biapenem 300 mg inj 368 KB
123 Sulbactam-ETX2514 427 KB
124 Rifapentine plus Isoniazid 259 KB
125 IQVIA 213 KB
126 Ropivacaine Readyfusor 2mg/mlIII 2629 KB
127 Toujeo 300 Units/ml 486 KB
128 Acotiamide ER tablet 300 tabletIII 2090 KB
129 Oral Galactose 252 KB
130 Semaglutide 429 KB
131 Semaglutide (NN9535-4352) 429 KB
132 Guselkumab 566 KB
133 Curcumin (Biocurcumax cap) as an adjunct drug to standard therapy [(Artesunate) + (Sulfadoxine-Pyrimethamine) tablet] 238 KB
134 2Ó-Methyl-Phosphorothioate Anti Sense Oligoribonucleotide for treating patients with Duchenne Muscular Dystrophy 231 KB
135 Xlucane versus Lucentis® 443 KB
136 Neoadjuvant/adjuvantDurvalumab 427 KB
137 Durvalumab 427 KB
138 Rituximab Biosimilar (DRL_RI) with MabThera® 434 KB
139 METREXASSIST™ 194 KB
140 Tirzepatide 432 KB
141 Baricitinib 194 KB
142 Phenobarbital Sodium Injection 191 KB
143 FDC of Daclatasvir Dihydrochloride Eq. to Daclatasvir 60mg Sofosbuvir 400mg film coated tablets (Phase IV) 1031 KB
144 C.O.M.B.A.T 222 KB
145 Sodium Fusidate eq. To Fusidic acid 2% w/w (Sofinox gel) 3105 KB
146 esidustat vs Darbepoetin 295 KB
147 Saroglitazar 2mg & 4mg Tablet 2767 KB
148 Olaparib 250 KB
149 Rivaroxaban tablets 2.5mg (Xarelto®) 2579 KB
150 Tacrolimus lipid tablet 3mg 2677 KB
151 Oral Nafithromycin vs oral Moxifloxacin 417 KB
152 TRC160334 295 KB
153 Fitusira 419 KB
154 SB12 and Soliris 202 KB
155 Galcanezumab 327 KB
156 Durvalumab 208 KB
157 SAR341402 Mix 70/30 to NovoMix®3 337 KB
158 Lasmiditan 334 KB
159 Norditropin® 427 KB
160 Pharmacokinetic and Pharmacodynamic 476 KB
161 Pharmacokinetics of Murepavadin 248 KB
162 Ipatasertib in Combination with Paclitaxel 194 KB
163 IMU-131 HER2/neu 427 KB
164 Bedaquiline, Delamanid, Linezolid and Clofazimine 267 KB
165 Octenidine Dihydrochloride 318 KB
166 Cetilistat 394 KB
167 Bibrocathol 2% Eye ointment 303 KB
168 Probiotic Supplementation lactic acid bacteria and Bifidobacteria, namely, L. Plantarum DSM24730, L. paracasei DSM 24733, L. delbrueckii subsp. Bulgaricus DSM 24734, L. acidophilus DSM24735, B. longam, DSM24736, B. Infantis DSM 24737, B. breve DSM 24732, and S. thermophilus DSM 24731 which is to be reconstituted with MCT oil drop with Medium Chain Triglyceride (MCT) oil 2042 KB
169 Norethisterone CR tablet 15mg 2068 KB
170 Teneligliptin and Sitagliptin 247 KB
171 secukinumab SUNSHINE 570 KB
172 Edoxaban tosylate 220 KB
173 Secukinumab SUNRISE 570 KB
174 iGlarLixi versus premixed 321 KB
175 Durvalumab in combination 423 KB
176 Alfuzosin Hydrochloride IP (extended release form) Tadalafil IP film coated tablets (Phase III) 1141 KB
177 Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil Cilnidipine film coated bilayaered tablet (Phase III) 1652 KB
178 Evaluation of Vitamin D Supplementation in affecting the outcome of newly Diagnosed patients with Lymphoma 217 KB
179 Oxaceprol tablet 600mg 1358 KB
180 Tacrolimus lipid suspension 4mg/vial 1294 KB
181 Baricitinib SLE 581 KB
182 Ofatumumab toterability 195 KB
183 Bepotastine besilate JP Montelukast Sodium IP tablets (Phase III) 1067 KB
184 Durvalumab Monotherapy 355 KB
185 Ivermectin Lotion,0.5% 223 KB
186 Beclomethasone Dipropionate 581 KB
187 Phase 3 Relamorelin 413 KB
188 JHL1101 498 KB
189 Benidipine Hydrochloride IP Telmisartan IP Film coated tablets (Phase III) 1695 KB
190 efficacy ART-123 439 KB
191 Relamorelin gastroparesis 238 KB
192 Mirabegron (in extended release) Solifenacin Succinate Film coated bilayered tablets (Phase III) 1117 KB
193 SHP640 196 KB
194 Teriflunomide tab 14 mg 428 KB
195 PNB028 266 KB
196 HRF-4467 228 KB
197 Durvalumab plus Olaparib 1481 KB
198 Prednisone delayed Release Tablet 5 mg 2670 KB
199 Itraconazole 1378 KB
200 Relamorelin 1680 KB
201 Durvalumab as Consolidation therapy 1497 KB
202 Dexamethasone Sodium Phosphate 1600 KB
203 Enbrel®’ (Etanercept 1379 KB
204 Single dose Del Nido vs multi dose StThomas II Cardioplegia 235 KB
205 CPL-2009-0031 tablet 140 mg of Cadila Pharmaceutical Ltd 222 KB
206 CPL-2009-0031 tablet 140 mg 277 KB
207 Azacitidine 239 KB
208 PMZ-2010 283 KB
209 Durvalumab 1405 KB
210 Pembrolizumab 1412 KB
211 LNP3794 in apatients 1411 KB
212 Crizanlizumab 1410 KB
213 Dupilumab 1781 KB
214 Ifetroban 1415 KB
215 Ivabradine Tablets 2291 KB
216 CT-P16 1586 KB
217 TX05 1595 KB
218 Herceptin® or TX05 1438 KB
219 tropifexor (LJN452) and cenicriviroc (CVC) 1460 KB
220 ZS (sodium zirconium cyclosilicate 1636 KB
221 ligelizumab (QGE031) 1696 KB
222 Cefepime-Tazobactam vs. Meropenem 1484 KB
223 Selinexor (KPT-330 1592 KB
224 PXL01 1568 KB
225 NexoBrid 1513 KB
226 Coversin 1489 KB
227 Adapalene and Benzoyl Peroxide Gel, 0.3%/2.5% 1449 KB
228 Aztreonam-Avibactam (Atm-Avi) 1491 KB
229 Semaglutide 1601KB
230 Ligelizumab (QGE031) 1614 KB
231 Azelnidipine tab 8 mg / 16 mg 287 KB
232 Azacitidine 100 mg 280 KB
233 Epinephrine plus Vasopressin 226KB
234 Saroglitazar Magnesium 17176 KN
235 VELPANAT 197 KB
236 Azelnidipine 371 KB
237 FDC of Efonidipine Hydrochloride Ethanolate + Metoprolol Succinate IP (as extended release) (20 mg+25mg & 20mg+50mg) Film coated tablets. 17177 KB
238 Pregabalin 212 KB
239 Doxycycline 225 KB
240 Bedaquiline, Delamanid, Linezolid and Clofazimine 218 KB
241 PMZ-1620 259 KB
242 Enterogermina 179 KB
243 Desidustat ZYAN1 236 KB
244 Tulobuterol Transdermal 239 KB
245 Nexagon® (NEXAGON) 1530 KB
246 Tapentadol nasal spray 225mg/ml 966 KB
247 Semaglutide 1637 KB
248 Nitazoxanide 500 mg Tablets 1696 KB
249 Ticagrelor 1672 KB
250 5-aminolevulinic acid hydrochloride 1845 KB
251 Brolucizumab 1822 KB
252 Aztreonam-Avibactam (ATM-AVI Pfizer 2029 KB
253 Granexin Gel 545 KB
254 KAF156 1902 KB
255 Osilodrostat (LCI699 1794 KB
256 Mirikizumab 1850 KB
257 Efpeglenatide 444 KB
258 Edoxaban 1794 KB
259 EG12014 1782 KB
260 Mirikizumab 1786 KB
261 LCZ696 1762 KB
262 Esmolol Hydrochloride 14.00% w/w topical gel 1298 KB
263 FDC of Daclatasvir dihydrochloride eq to Daclatasvir 60mg + Sofosbuvir 400mg film coated tablets 1246 KB
264 Clostridium Botulinum Type-A Toxin Haemagglutinin complex injection 300 units 1737 KB
265 Dalfampridine 124 KB
266 Osimertinib 1773 KB
267 Apremilast Tablets 10/20/30mg Phase IV . 1708 KB
268 FDC of Metoprolol Succinate ER + Cilnidipine +Telmisartan (25mg + 10mg + 40mg & 50mg + 10mg + 40mg) Tablets 1300 KB
269 FDC of Metoprolol Tartrate IP + Ivabradine HCL eq to Ivabradine (25mg+5mg & 50mg+5mg) Film coated tablets 1316 KB
270 EG12014 1782 KB
271 LCZ696 1762 KB
272 Mirikizumab 1850 KB
273 Mirikizumab 1786 KB
274 Osilodrostat (LCI699 1794 KB
275 Edoxaban 1794 KB
276 Paracetamol Injection 500mg/2ml for IM route Phase III 1960 KB
277 Pilot study on Paracetamol Injection for IM route Pilot study 1593 KB
278 Bilastine 20 mg 312 KB
279 Magnesium sulfate 116 KB
280 Dolutegravir (Phase IV) 78.6 KB
281 TRC041266 195 KB
282 Nitazoxanide 500 mg Tablets 1696 KB
283 Scrub Typhus INTREST 1820 KB
284 Granexin Gel 545 KB
285 Aztreonam-Avibactam (ATM-AVI 2029 KB
286 Brolucizumab 1822 KB
287 5-aminolevulinic acid hydrochloride 1854 KB
288 Ticagrelor 1672 KB
289 KAF156 1902 KB
290 Sodium Copper Chlorophyllin 155 KB
291 Tagrisso (Osimertinib) 137 KB
292 Kyprolis (Carfilzomib) 184 KB
293 Alcaftadine 0.25% w/v + Ketoroloc Tromethamine 0.4% w/v Eye drops (Phase-III). 1,163 KB
294 Tadalafil + Dapoxetine (20mg +60mg, 20mg+30mg, 10mg+30mg) film coated tablets (Phase-III). 949 KB
295 Azilsartan Medoxomil + Chlorthalidone (40mg+25mg,40mg+12.5mg 40mg+6.25mg) Tablets (Phase-III). 1,118 KB
296 Efonidipine Hydrochloride Ethanolate 20mg + Telmisartan IP 40mg film coated Tablets (Phase-III) 1,008 KB
297 Metoprolol Succinate ER + Chlorthalidone + Telmisartan (50mg+12.5mg+40mg, 25mg+12.5mg+40mg)film coated tablets (Phase-III) 1,027 KB
298 Pregabalin IP (As Prolonged Release) 75mg + Etoricoxib IP 60mg uncoated bilayered tablets (Phase-III). 1,195 KB
299 Sotagliflozin 1,910 KB
300 Cinacalcet Hydrochloride 1,710 KB
301 Semaglutide 2.4 mg 1,708 KB
302 Semaglutide 2.4 mg 1,722 KB
303 Durvalumab 260 KB
304 Efpeglenatide 444 KB
305 emaglutide 2.4 mg CT/18/000019 1,708 KB
306 Filgotinib 1,786 KB
307 Desidustat 106 KB
308 Delamanid 82 KB
309 Azelnidipine tab 16 mg 130 KB
310 Enzalutamide 98.6 KB
311 Calcipotriol/AKVANO 50 µg/g cutaneous solution 1,737,836 KB
312 Efpeglenatide 444 KB
313 Permission for conducting A Phase 3 clinical trial titled "ATLAS- INH: A Phase 3 Study to Evaluate the Efficacy and Safety of Fitusiran in Patients With Hemophilia A or B, With Inhibitory Antibodies to Factor VIII or IX 143KB
314 Permission for conducting a Phase rB/IlA 'clinical study entitled , "A Phase IS /IrA, multi-center , open-label clinical trial to evaluate the safety, to lerability and pharmacokinetic of Desidustat for the patients with Chronic Kidney Disease (CKD) on Dialysis " 97KB
315 Permission for conducting a clinical study entitle d, "A multicentric , Randomized , double blind , parallel group, comparative, Phase 3 clinical study to evaluate the efficacy, Safety and Tolerability of Azelnidipine Tablets 16 mg verus Amlodipine Tablets 10 mg in subjects with essential hypertension " 128KB
316 Permission for conducting a clinical study entitled "A Phase-l/ll open label, single arm study to evaluate the pharmacokinetic, safety and tolerability of Delamanid in combination with optimized Multidrug Background Regimen (OBR) for multidrug-Resistant Tuberculosis (MDRTB) in HIV infected and HIV-uninfected children with MDR-TB" 76KB
317 Ivermectin topical lotion 0.5% w/w 1,858,593 KB
318 Darunavir Tablet 800mg 143KB
319 Permission for conducting a clinical study entitled , "A multicenter Phase-4 , Open-label, Single-arm, Safety and Efficacy Study of Enzalutarnide in Indian Patients with Progressive Metastatic Castration -Resistant Prostate Cancer (mCRPC) Previously Treated with Docetaxel-Based Chemotherapy" 105KB
320 Erdafitinib 1803 KB
321 Canakinumab 1877 KB
322 Paliperidone Palmitate 1757 KB
323 Rigosertib 1688 KB
324 Atezolizumab 1769 KB
325 Fitusiran 1875 KB
326 Emicizumab 371KB
327 AMG 334 392KB
328 Baricitinib 300KB
329 Torsemide Extended Release 568KB
330 QAW039 570KB
331 SCY 078 242KB
332 Baricitinib 300KB
333 Exenatide 373KB
334 YLB113 299KB
335 Rilpivirine 577KB
336 MB02 (Bevacizumab Biosimilar Drug) 573KB
337 NexoBrid 302KB
338 Fitusiran 1758 KB
339 Pimodivir15 1640 KB
340 CLS-TA 1814 KB
341 Pimodivir 1718 KB
342 ASN100 1753 KB
343 MEDI-551 1763 KB
344 Regorafenib 140KB
345 Fluticasone Propionate 100 mcg and Salmeterol 50 mcg 1750 KB
346 QVM149 1804 KB
347 Lenvatinib 143KB
348 Sofosbuvir / Velpatasvir FDC 100KB
349 Februric (Febuxostat) 103KB
350 Pirfenidone 100KB
351 Anagliptin 162KB
352 Verapamil ER 193KB
353 Heptral 105KB
354 Spironolactone cream 5% 926KB
355 Heptral 105kb
356 BIO-11006 565 KB
357 Ataluren 269 KB
358 LUBT010 371 KB
359 ABP 798 340 KB
360 Nintedanib Systemic Sclerosis 404 KB
361 Selinexor (KPT-330) 445 KB
362 ribociclib with endocrine 423 KB
363 Canagliflozin in Children 439 KB
364 Dapagliflozin 5 and 10 mg 447 KB
365 Povidone-Iodine Nail Solution 103 KB
366 Atezolizumab compared with chemotherapy 109 KB
367 SB11 282 KB
368 Dinutuximab and Irinotecan 456 KB
369 Lorlatinib (PF-06463922) 470 KB
370 Denosumab 320 KB
371 CLS-TA Sapphire 100 KB
372 Selinexor 448 KB
373 Bempedoic Acid (ETC-1002) 582 KB
374 LJN452 367 KB
375 Atezolizumab(ANTI-PD-L1Antibody) 907 KB
376 Deferasirox Formulation(Granules) 842 KB
377 Ticagrlor 1115 KB
378 Ruxolitinib 849 KB
379 LCZ696 on NT Pro BNP 1117 KB
380 Ixekizumab 1165 KB
381 Alpelisib 861 KB
382 QAW039 sept 1132 KB
383 PEGylated factor 1154 KB
384 Abemaciclib 1210 KB
385 Apixaban 1104 KB
386 RSV 868 KB
387 Empagliflozin 10mg 1138 KB
388 Empagliflozin 1228 KB
389 LY900014 (Insulin Lispro) 1115 KB
390 Dapagliflozin PC D1699C00001 1064 KB
391 MOD-4023 1274 KB
392 SAIT101 vs Rituximab 1353 KB
393 LNP1892 1018 KB
394 QMF149 150-80 microgram 1039 KB
395 Eltrombopag 867 KB
396 Dulaglutide 985 KB
397 ovidone -Iodine 1133 KB
398 Ribociclib 846 KB
399 Safety Study of Atezolizumab 814 KB
400 Canagliflozin 1121 KB
401 ANF-Rho 1125 KB
402 SPI-2012 876 KB
403 Filgotinib Rheumatoid 842 KB
404 Filgotinib Crohn 1203 KB
405 Filgotinib combined phase 1008 KB
406 LNP3794 819 KB
407 sFilgotinib 1171 KB
408 Secukinumab 888 KB
409 Filgotinib Administered 196 KB
410 Tenofovir Alafenamide 1111 KB
411 LY900014 1048 KB
412 Filgotinib 198 KB
413 Dapagliflozin 1168 KB
414 CLS-TA 59 KB
415 Filgotinib safety 1238 KB
416 Selonsertib NASH 1326 KB
417 Selonsertib 1320 KB
418 Masitinib vs Placebo 807 KB
419 Pemafibrate 1356 KB
420 Ribociclib LEE011 831 KB
421 Bedaquiline 152 KB
422 Daprodustat 183 KB
423 aprodustat 227 KB
424 Oral Semaglutide versus 192 KB
425 LCZ696 145 KB
426 SAIT101 148 KB
427 Alphanate® 139 KB
428 TK-112690 172 KB
429 Etrolizumab 207 KB
430 Ofatumumab safety 186 KB
431 Etrolizumab PhaseII/III 204 KB
432 Ofatumumab 188 KB
433 Clindamycin phosphate 178 KB
434 Pradaxa Capsules 155 KB
435 DE-117 200 KB
436 Lixisenatide 204 KB
437 QVA149 294 KB
438 Aclidinium 229 KB
439 Nintedanib oral 197 KB
440 Sarizotan 142 KB
441 Avelumab 150 KB
442 LY2835219 295 KB
443 Insulin Degludec 156 KB
444 FIASP 143 KB
445 Palbociclib 178 KB
446 CBT124 222 KB
447 Guidance Document for Export NOC 137kb
448 Guidance document for Functions and Responsibilities of Zonal, Sub-zonal & port offices of CDSCO 4,818kb
449 Guidance for global access of OCTAMS 1,138kb
450 Manual of OCTAMS 4,561kb
451 Report Book 5,165kb
452 Sofosbuvir Velpatasvir 158 KB
453 Cardiovascular safety of Oral Semaglutide 216 KB
454 Budesonide 150 KB
455 MYL-14020 280 KB
456 Vedolizumab IV 152 KB
457 Dexamethasone sodium 141 KB
458 Pegylated Interferon @-2a 143 KB
459 NC0195-0092 130 KB
460 BCD-055 148 KB
461 Liraglutide 136 KB
462 QAW039 128 KB
463 Oral Semaglutide 133 KB
464 GS-5745 138 KB
465 RFB002 135 KB
466 Semaglutide IGlar SGT2i 160 KB
467 Trimcinolone Acetonide 173 KB
468 Rivaroxaban 148 KB
469 MEDI4736 aug 211 KB
470 Ceritinib 144 KB
471 MEDI4736 189 KB
472 INC280 2112 KB
473 Ticagrelor 158 KB
474 QMF149 225 KB
475 Indacaterol 277 KB
476 Insulin Aspart 195 KB
477 NW-3509A 153 KB
478 BIASP-30 198 KB
479 Lopinavir/Ritonavir 144 KB
480 Insulin degludec may 216 KB
481 MDR-TB Drugs 151 KB
482 B1695502 225 KB
483 Sofosbuvir 143 KB
484 RLX030 190 KB
485 Clindamycin 189 KB
486 Semaglutide 2016 256 KB
487 Masitinib 178 KB
488 Carbetocin RTS 1542 KB
489 YLB113 184 KB
490 Insulin degludec 245 KB
491 BYL719 189 KB
492 LEE011 183 KB
493 Nintedanib 204 KB
494 Pregabali 182 KB
495 Bevacizumab 181 KB
496 Pregabalin 182 KB
497 Recruitment Rule of Drugs Inspector in CDSCO 2,512kb
498 Alirocumab 191 KB
499 CT P10 186 KB
500 QGE031 S.c 191 KB
501 QGE031 CQGE031B2201 166 KB
502 FG-3019s 190 KB
503 Roxadustat 187 KB
504 Roxadustat Anemia 190 KB
505 GENA-05 160 KB
506 Dydrogesterone 178 KB
507 Subcutaneous Secukinumab 221 KB
508 Pregabalin as adjunctive 171 KB
509 Linaclotide 225 KB
510 LCZ696 NYHA 204 KB
511 LCZ696 Paradigm 235 KB
512 Moroctocog alfa 166 KB
513 RanibizumAB 173 KB
514 Steroids in Iga 181 KB
515 Canagloflozin 209 KB
516 Insulin Aspart BIAsp 201 KB
517 Salmeterol 193 KB
518 Masitinib Lymphoma 189 KB
519 LEE011 NSAI 182 KB
520 Checklist for Test License Appli8cations Effective From 15 June 2011 143kb
521 Guidance Document on Grant of Licenses in Form 11(Test License) 618kb
522 Amended Checklist for test License Applications Effective From 15 June2011 69kb
523 DE-109 180 KB
524 Octafibrin 170 KB
525 ACTG 5288 170 KB
526 Dabigatran etexilate dual 239 KB
527 Clindamycin 1% 215 KB
528 LEE011 with Lerozole 184 KB
529 Bococizumab 369 KB
530 Bococizumab PF-04950615) 368 KB
531 Masitinib 210 KB
532 Masitinib Folfiri 209 KB
533 Fibrinogen 182 KB
534 Dabigatran Etexilate 255 KB
535 Dabigatran 197 KB
536 Chemotherapy 178 KB
537 Rituximab 190 KB
538 2 PARALLEL Masitinib 213 KB
539 Chemoradiation 162 KB
540 Ticagelor 189 KB
541 QGE031 183 KB
542 Isoniazid 172 KB
543 Tiotropium 265 KB
544 DS-5565 178 KB
545 Labetalol 162 KB
546 Nifedipine Daga 165 KB
547 Nifedipine Daga 165 KB
548 NNC0195-0092 188 KB
549 Insulin Detemir 181 KB
550 LY2963019 200 KB
551 Mifepristone 160 KB
552 LCI699 173 KB
553 Mifepristone and Misoprotol 163 KB
554 Pasireotide 173 KB
555 Pasireotidestudy 171 KB
556 Policy Initiatives Planned for 2015 85kb
557 Antidepressant 149 KB
558 LY2605541 200 KB
559 Octafibrin GCT/64/14 197 KB
560 Semaglutide 2014 198 KB
561 Alglucosidase Alfa 164 KB
562 Dabigatran BI 655075 223 KB
563 Ranibizumab VEGF 180 KB
564 Ranibizumab CRVO 180 KB
565 Ranibizumab Brilliance 191 KB
566 Trastuzumab 216 KB
567 Afatinib for Patients 172 KB
568 Rituximab RTXM83 185 KB
569 Afatinib BiBW 2992 189 KB
570 Alglucosidase 171 KB
571 Pregabalin Adjunctive 188 KB
572 Herpes Zoster 169 KB
573 Paclitaxel 178 KB
574 Eravacycline 197 KB
575 UT-15C Phase III 189 KB
576 Dapagliflozin 10mg 201 KB
577 UT-15C 176 KB
578 Bevacizumab AVASTIN 178 KB
579 Pertuzumab 180 KB
580 LDK378 219 KB
581 Pasireotide LAR 163 KB
582 FactorVIII 122 KB
583 Ifetroban Injection 192 KB
584 Baricitinib in Patients 222 KB
585 Adalimumab 179 KB
586 Cyclosporine 190 KB
587 Fluocinolone acetonide intravitreal 174 KB
588 Ranibizumab 0.5 mg 188 KB
589 Everolimus with reduced calcineurin 256 KB
590 Fosaprepitant 191 KB
591 Liraglutide Sitagliptin 181 KB
592 Masitinib 198 KB
593 Sitagliptin 213 KB
594 NOVA22007 191 KB
595 QAW039 on FEV1 184 KB
596 Clindamycin benzoyal peroxide 265 KB
597 BCD-020 223 KB
598 Pasireotide S.C 173 KB
599 Ciprodex 212 KB
600 Daclizumab 186 KB
601 Ceftazidime CAZ AVI 200 KB
602 Exenatide 174 KB
603 Enbrel 194 KB
604 Remicade 215 KB
605 BCD-021 214 KB
606 Buparlisib 182 KB
607 Insulin Degludec versus insulin glargine 277 KB
608 Liraglutide versus sulphonylurea 211 KB
609 BCD-022 217 KB
610 tolerability of Secukinumab 176 KB
611 Everolimus alone 183 KB
612 Everolimus RADOO1 192 KB
613 Transfer Policy 421kb
614 SAR236553 681 KB
615 Afatinib 225 KB
616 subcutaneous Secukinumab 166 KB
617 Sofosbuvir plus ribavirin 291 KB
618 Ceftazidime 283 KB
619 Fluocinolone 292 KB
620 Everolimus 243 KB
621 FLU D-QIV 278 KB
622 FIAsP Insulin 280 KB
623 FIAsP 2014 279 KB
624 Tenofovir Disoproxil 303 KB
625 Tenofovir Alafenamide TAF 314 KB
626 olasertib 289 KB
627 Baricitinib 357 KB
628 Diclofenac Gel 370 KB
629 Baricitinib LY3009104 348 KB
630 TechnologyMG145 1410 KB
631 BEZ235 846 KB
632 Producttrastuzumab 926 KB
633 LAF237 293 KB
634 Liraglutide sc Injection 306 KB
635 Fesoterodine 305 KB
636 Human rh FV III 301 KB
637 Lixisenatid Subcutaneous 382 KB
638 Octefibrin 290 KB
639 CP-690,550 296 KB
640 Tenofovir 342 KB
641 ART-123 303 KB
642 Quotation of rate contract for supply of Photostat Paper (JK Brand) Last date (27 Jul 2012 ) 129kb
643 Re-tendering for Housekeeping and General cleanliness in the CDSCO(HQ), FDA Bhawan, Kotla Road, New Delhi Last Date ( 27 Jul 2012 ) 903kb
644 Extension of Date of Notice Inviting Tender (NIT) Last Date( 27 Jul 2012 ) 370kb
645 Annual Rate Contract for Hiring taxies 1 Last Date( 27 Jul 2012 ) 132kb
646 Annual Rate Contract for Hiring taxies 2 Last Date ( 27 Jul 2012 ) 1,775kb
647 Annual Rate Contract for Hiring taxies 3 Last Date( 27 Jul 2012 ) 162kb